Studies suggest that different autoimmune diseases share a common genetic background, in particular, an overlap between Multiple Sclerosis (MS) and type 1 diabetes (T1D) susceptibility loci has been established. A recent study found that four rare SNPs in the IFIH1 (interferon induced with helicase C domain 1) were significantly associated with T1D. To establish if these SNPs were also involved in MS susceptibility, we chose to examine the non-synonymous SNP rs35667974/Ile923Val which displayed the strongest effect in T1D and was also shown to lead to a loss of IFIH1 function in an in vitro study. We have performed the first association study to test if this rare variant is involved in MS susceptibility in a very large sample consisting of 3037 MS patients and 10,657 healthy controls recruited from Italy and the UK. This study has 99% power to demonstrate an association at the 5% level with this rare variant. Our analysis shows that the nsSNP rs35667974/Ile923Val does not have a role in susceptibility to MS.
Introduction
Different autoimmune diseases can share a common genetic background (Zhernakova et al., 2009 ). This was originally hypothesised by epidemiological studies which observed an increased risk of a second autoimmune disorder in patients, and/or in the families of patients, affected by an autoimmune disease and confirmed by the recent identification of susceptibility genes shared by different autoimmune diseases (Zhernakova et al., 2009) . In this respect, the relationship between type 1 diabetes (T1D) and Multiple Sclerosis (MS) is particularly intriguing, in view of recent studies showing that several genes associated with T1D (such as IL7R, IL2RA, CLEC16A, CD226 and SH2B3) are also robustly associated with MS (Zhernakova et al., 2009; IMSGC, 2009 ). These observations further support the hypothesis that loci associated with one autoimmune disease are possible candidates for other autoimmune disorders.
Among the recently identified T1D genes, IFIH1 (interferon induced with helicase C domain 1) also represents an interesting candidate for MS. IFIH1, mapping on chromosome 2q24, codes for a cytoplasmic protein mediating immune activation and induction of interferon production in response to the recognition of viral double strand RNA. Epidemiological and experimental data strongly suggest that infectious agents could be triggering elements in the development of MS, especially in genetically predisposed individuals (Ascherio and Munger, 2007; Serafini et al., 2007; Challoner et al., 1995; Sriram et al., 1999) .
A first series of association studies in T1D suggests that the minor allele of a common non-synonymous SNP (nsSNP) rs1990760/Thr946Ala in the IFIH1 gene confers a protective effect (Smyth et al., 2006; Liu et al., 2009 ). This variant is not associated with MS as demonstrated by a recent large study of over 18,000 individuals recruited from six countries (IMSGC, 2009 ).
More recently, Nejentsev et al. (2009), using new high-throughput sequencing technology, identified 29 rare SNPs in IFIH1 in UK T1D patients and/or matched controls, and found that four of these variants (two coding and two intronic mutations) were significantly associated with T1D. Moreover, the association of these four SNPs was independent of the previously identified rs1990760/Thr946Ala T1D associated variant. These independent effects prompted us to investigate the association of rare IFIH1 variants in MS. Among the four rare IFIH1 variants, we selected the nsSNP rs35667974/Ile923Val since it displayed the strongest effect in T1D (OR = 0.51 95% CI: 0.43-0.61, for the minor allele, p = 2.1 × 10 − 16 ) (Nejentsev et al., 2009) . In vitro studies have demonstrated that this variant, but not the common Thr946Ala, results in loss of IFIH1 function (Shigemoto et al., 2009 ).
Materials and methods

Samples
We analyzed a large sample of MS patients and healthy matched controls recruited from the Italian (827 MS patients and 628 controls)
